Brief: Ascelia Pharma Submits Orviglance New Drug Application To FDA

Ascelia Pharma AB

03/09/2025 09:11

Sept 3 (Reuters) - Ascelia Pharma AB ACELP.ST:

SUBMITS ORVIGLANCE NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION

FDA STANDARD REVIEW TIMELINE IS 10 MONTHS

Source text: ID:nMFN6j2WB2

Further company coverage: ACELP.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))